Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma

Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive disease with poor outcomes in patients ineligible for autologous stem cell transplantation. In this setting, novel treatment approaches are urgently required and the innovative agent pixantrone has shown some promising res...

Descripción completa

Detalles Bibliográficos
Autores principales: Novakovic, Aleksander, Boltezar, Lucka, Novakovic, Barbara Jezersek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039066/
https://www.ncbi.nlm.nih.gov/pubmed/32194699
http://dx.doi.org/10.3892/ol.2020.11288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039066/
https://www.ncbi.nlm.nih.gov/pubmed/32194699
http://dx.doi.org/10.3892/ol.2020.11288

Ejemplares similares